The American laboratory Moderna closed 2021 with a net profit of 12,202 million dollars (10,982 million euros) compared to the losses of 747 million (672 million euros) that it recorded in the previous year, thanks to the millions of doses sold of Spikevax, your COVID-19 vaccine.

Between January and December, the firm invoiced 18,471 million (16,625 million euros), compared to the 803 million (723 million euros) that it entered in 2020. This change is due to the fact that the vaccines began to be marketed robustly in 2021.

Income from vaccines was 17,675 million (15,909 million euros), compared to 200 million (180 million euros) the previous year, while income from subsidies grew by 38.9 %, to 735 million dollars (€662 million).

The cost of goods sold was 2,617 million (2,356 million euros), practically without comparison with 2020 while selling expenses, general and administrative expenses multiplied by three, to 567 million (510 million euros). The research and development (R&D) item expanded by 45.3 %, to 1,991 million (1,792 million euros).

Only in the fourth quarter of the year, the laboratory registered net profits of 4,868 million (4,382 million euros), compared to losses of 272 million (245 million euros) the previous year. Turnover stood at 7,211 million (6,490 million euros), compared to 571 million (514 million euros) in the last quarter of 2020.

 Source: dpa

La entrada Moderna earns $12 billion from its Spikevax vaccine apareció primero en Bitfinance.

The director of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, believes that China should cooperate more in the investigation into the origins of the coronavirus pandemic, the first cases of which were detected in December 2019 in Wuhan.

These statements were made by the WHO representative at a press conference in Geneva, where he stated: “We hope there will be better cooperation so that we know what really happened.“

Additionally, Ghebreyesus also referred to the conclusions of an investigation being carried out jointly by Chinese scientists and members of the WHO that indicated that there was little probability of the leakage of the coronavirus.

For the WHO representative, it would be essential to share all the data that make up the study and analyze it to determine what really happened. “The first problem is to share the raw data and I said from the conclusions of the first phase of the investigation that this problem had to be solved; and, the second, is that there was a premature attempt to reduce the number of hypotheses such as that of the laboratory in transmission to humans”, Tedros indicated.

According to the conclusions of this joint investigation, a leak of the new coronavirus was “very unlikely, although the thesis of transmission from an animal to a person through an intermediate animal, not yet identified, prevailed.”

M. Rodríguez

Source: eluniversal.com

La entrada WHO requests cooperation from China for Covid-19 investigation apareció primero en Bitfinance.